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Wnt Target Genes Identified by DNA Microarrays in
Immature CD34 Thymocytes Regulate Proliferation and Cell
Adhesion1
Frank J. T. Staal, Floor Weerkamp, Miranda R. M. Baert, Caroline M. M. van den Burg,
Mascha van Noort, Edwin F. E. de Haas, and Jacques J. M. van Dongen2
The thymus is seeded by very small numbers of progenitor cells that undergo massive proliferation before differentiation and
rearrangement of TCR genes occurs. Various signals mediate proliferation and differentiation of these cells, including Wnt signals.
Wnt signals induce the interaction of the cytoplasmic cofactor -catenin with nuclear T cell factor (TCF) transcription factors. We
identified target genes of the Wnt/-catenin/TCF pathway in the most immature (CD4CD8CD34) thymocytes using Af-
fymetrix DNA microarrays in combination with three different functional assays for in vitro induction of Wnt signaling. A
relatively small number (30) of genes changed expression, including several proliferation-inducing transcription factors such as
c-fos and c-jun, protein phosphatases, and adhesion molecules, but no genes involved in differentiation to mature T cell stages. The
adhesion molecules likely confine the proliferating immature thymocytes to the appropriate anatomical sites in the thymus. For
several of these target genes, we validated that they are true Wnt/-catenin/TCF target genes using real-time quantitative PCR
and reporter gene assays. The same core set of genes was repressed in Tcf-1-null mice, explaining the block in early thymocyte
development in these mice. In conclusion, Wnt signals mediate proliferation and cell adhesion, but not differentiation of the
immature thymic progenitor pool. The Journal of Immunology, 2004, 172: 1099–1108.
T he Wnt protein family consists of 18 secreted factors thatregulate cell fate, polarity, and cell growth in receptivecells (1). Many of the Wnt genes in the mouse have been
investigated by targeted mutation, leading to very specific devel-
opmental defects (2). In addition, deregulated Wnt signaling is
involved in oncogenesis of several different types of human can-
cers, including tumors of the colon, kidney, liver, prostate, and
ovarium (3). Current models of Wnt signaling assume that secreted
Wnt proteins bind to receptors of the Frizzled family on the cell
surface. Via several different proteins, the signal is transduced to
cytoplasmic -catenin, which then enters the nucleus and forms a
complex with members of the T cell factor (TCF)3 family of tran-
scription factors to activate transcription of Wnt target genes (4).
The founding members of the TCF family are Tcf-1 and lym-
phoid enhancing factor-1 (Lef-1) (5). In adult mammals, Tcf-1 is
expressed uniquely in T lymphocytes, whereas Lef-1 is expressed
at lower levels in T cells, as well as in B cells and other cell types
(6). The functions of both of these genes have been investigated by
targeted mutation experiments. Tcf-1-null mice have an incom-
plete, but marked block in thymocyte development (7), and fail to
generate de novo thymocytes after transplantation of hemopoietic
precursors in irradiated hosts (8). Two different Tcf-1 mutant mice
have been generated (7). In Tcf-1(V) mutant mice, a low level of
a truncated yet functional Tcf-1 is still expressed, whereas the
Tcf-1(VII) mutation abolishes the DNA binding activity of Tcf-1
completely, and these mice are regarded as true Tcf-1-null mu-
tants. Young Tcf-1(VII)/ mice have an incomplete block at the
CD4CD8 double-negative (DN) and a more prominent block at
the immature single-positive (ISP) stages of thymocyte differenti-
ation, whereas older mice display a complete block at the DN1
stage of development. Lef-1-null mice lack hair, teeth, mammary
glands, and trigeminal nuclei, and die around birth (9), but have
normal thymocyte development. Lef-1 can partially compensate
for the Tcf-1 defect, especially in the neonatal and fetal thymus.
Although Tcf-1(V) mutant mice are viable and have modestly im-
paired thymocyte development, Lef-1/Tcf-1(V) double-mutant
mice display a complete block in thymocyte development at the
ISP stage (10). Lef-1/Tcf-1(VII) double-mutant mice die at day 10
of embryogenesis (11) with dramatic developmental defects af-
fecting the limb buds and neural tube. Interestingly, the phenotypic
abnormalities of these double-mutant mice are highly reminiscent
of those in Wnt3A mutant mice (11).
Both Tcf-1 and Lef-1 function as nuclear effectors of Wnt sig-
nals (12, 13). Both nuclear proteins are activated by binding to
-catenin, which supplies a powerful transactivation domain to the
DNA binding activity of TCFs. -Catenin is subject to complex
regulation via several key components of the Wnt pathway, in-
cluding the tumor suppressor genes Axin and adenomous polyposis
coli and the negative regulatory protein kinase glycogen synthase
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kinase-3 (GSK-3) (1) (see Fig. 1). In absence of Wnt signaling,
GSK-3 is actively inducing phosphorylation of -catenin and its
subsequent degradation via the ubiquitin/proteasome pathway. In
the absence of -catenin in the nucleus, TCFs may recruit mem-
bers of the transducin-like enhancer of split/Grg family, which act
as global repressors of transcription (14). Upon Wnt signaling,
GSK-3 is inactivated, leading to accumulation of dephosphory-
lated -catenin. Lithium can strongly inhibit GSK-3 activity and
can therefore be used to mimic Wnt signaling (15). Lithium treat-
ment can activate transcription of TCF reporter genes in fibroblasts
and epithelial lines (15) and, to a lesser extent, in T cells (16).
Wnt signaling has been shown to occur in hemopoietic stem
cells (HSC) and developing T and B cells (17–20). Several reports
indicate that Wnts can act in synergy with cytokines as hemopoi-
etic growth factors. For instance, Wnts induce expansion of murine
fetal liver stem cells and induce proliferation of human CD34
HSC (17). In addition, Reya et al. (18) demonstrated that Wnts can
act as growth factors for pro-B cells. We have shown that Wnt
signaling induces proliferation of fetal DN thymocytes (19). More-
over, retroviral expression of soluble Wnt receptor mutants that
block Wnt signaling impairs thymocyte development, indicating
that Wnt signaling is required for normal T cell development (19).
Finally, Wnt signaling is important in the regulation of survival of
double-positive (DP) thymocytes (20).
To further understand the role of Wnt signaling in T cell devel-
opment, it is imperative to identify the target genes of the -cate-
nin/TCF transcription factor complex in thymocytes. The recent
development of DNA microarrays allows the rapid and unbiased
identification of genes expressed under different conditions. We
have chosen to purify human CD34 DN thymocytes instead of
murine early DN thymocytes for several reasons. First, many more
thymocytes can be obtained from human thymi than from the
mouse. Given that the most immature DN thymocytes (DN1 and
DN2) comprise only a small (1%) subset of adult thymocytes,
the choice of human thymocytes allows more readily the isolation
of sufficient amounts of RNA for use on DNA microarrays. Sec-
ond, the currently available microarrays for humans generally con-
tain more genes than the murine chips. Third, human immature
thymocytes can easily be purified based on the presence of the
CD34 stem/progenitor cell marker on their cell surface. In this
study, we have used Affymetrix (Santa Clara, CA) microarrays to
identify the transcriptional response of the Wnt/-catenin/TCF
pathway in the most immature thymocytes.
Materials and Methods
Isolation of immature human thymocytes
Thymic tissue was obtained from children undergoing cardiac surgery who
did not have any immunological abnormalities. All tissues were obtained
according to the guidelines of the Medical Ethical Committee (Institutional
Review Board) of Erasmus MC. Thymocytes were isolated by mechanical
disrupture of the tissue and squeezing through a mesh. Thymocytes were
frozen in liquid nitrogen in RPMI 1640 medium containing 10% FCS and
10% DMSO. Thymocytes from 5–10 donors were pooled to reduce indi-
vidual variation. After thawing, pooling, and Ficoll density centrifugation,
CD34 thymocytes were purified by MACS (Miltenyi Biotec, Bergisch
Gladbach, Germany), according to standard protocols. The degree of pu-
rification was assessed by flow cytometry.
Isolation of murine thymocytes
Thymi were removed from 7-wk-old C57BL/6 and Tcf-1(VII)-null mice
(backcrossed to C57BL/6). Cell suspensions were made and stained with
Abs specific for mouse CD4, CD8, and CD3. DN and ISP subpopulations
were sorted on a FACS Digital Vantage (DiVa) cell sorter (BD Bio-
sciences, San Jose, CA) to 98% purity and immediately used for RNA
isolation.
Methods for in vitro induction of the Wnt/-catenin/TCF
pathway
Treatment with pharmacological agents. CD34 thymocytes (10  106)
were treated with 20 mM LiCl or KCl as control for the indicated length of
time. In some experiments, cells were also treated with the protein syn-
thesis inhibitor cycloheximide (CHX; 1 g/ml). These treatments were
done in the presence of 10 ng/ml human IL-7 to make the results compa-
rable to the retroviral transduction data. LiCl-induced Wnt signaling was
assessed by staining of dephosphorylated -catenin (21).
Retroviral transduction. The retroviral plasmids LZRS-S33--catenin-
IRES-Lyt2a and LZRS-IRES-Lyt2a (as control) were constructed and
transfected into Phoenix amphotropic packaging cell lines using Fugene-6
(Roche Molecular Biochemicals, Branchbury, NY). Stable high-titer pro-
ducer clones were selected with puromycin (1 g/ml). CD34 thymocytes
(30–50  106) were prestimulated with IL-7 (10 ng/ml) for 1 day, and
subsequently transduced using Retronectin-coated petri dishes (Takara,
Shiga, Japan) and recombinant retrovirus containing supernatant for 2
days, with daily replenishing of retroviral supernatant. The efficiency of the
retroviral transduction was evaluated by flow cytometry. Cells were stained
with Abs against human CD34 and mouse CD8 (Lyt2a) and analyzed on a
FACSCalibur flow cytometer using CellQuest Pro software (BD Bio-
sciences).
Stimulation with Wnt3A-containing supernatant. For stimulation with
Wnt3A, cells were incubated with conditioned medium from L cells stably
transfected with a pCDNA-Wnt3A construct. The supernatant was filtered
through a 0.22-m filter and incubated with immature thymocytes for 4 h,
using supernatant from parental L cells as negative control.
Induction of Wnt signaling in CD34 thymocytes by Wnt3A was as-
sessed by Western blotting. In short, immature thymocytes were isolated,
treated with Wnt3A or control supernatant, and lysed in boiling 2 SDS
sample buffer as described (21). Lysates were run on a 10% SDS-PAGE
gel, blotted, and stained with an Ab against the activated form of -catenin
(anti-ABC) (21, 22) or a pan--catenin Ab (Transduction Labs, Lexington,
KY) and visualized by ECL (Amersham, Little Chalfont, U.K.). Treatment
with LiCl or KCl was used as extra positive or negative control for detec-
tion of activated -catenin
Microarray analysis
RNA was isolated using RNeasy columns as described by the manufacturer
(Qiagen, Hilden, Germany). The integrity of the RNA was tested on 1%
formaldehyde-containing agarose gels. Five to 8 g of RNA was used to
generate double-stranded cDNA using SuperScript reverse transcriptase
and a T7-oligo(dT) primer. The resulting cDNA was used in an in vitro
cRNA reaction using T7 RNA polymerase and biotinylated ribonucleotides
using an ENZO (Farmingdale, NY) kit. The biotinylated cRNA was
cleaned up using RNeasy spin columns (Qiagen) and quantified by spec-
tophotometric methods. An adjusted cRNA yield was calculated to reflect
carryover of unlabeled total RNA. Fragmentation of 20 g of cRNA was
performed at 95°C for 35 min. Five micrograms of cRNA were hybridized
to a Test3 microarray (Affymetrix) to check the quality of the procedure.
Ten micrograms of fragmented cRNA was subsequently hybridized for
16 h to U95Av2 microarrays (Affymetrix) at 45°C. After washing and
staining, the arrays were scanned in a Hewlett-Packard/Affymetrix scanner
at 570 nm. For all experiments reported here, the 5/3 ratios of GAPDH
were 1.5 or less (usually 0.9–1.1). In comparison experiments, care was
taken that the scaling factor, noise, and presence calls were comparable.
Bioinformatics
Data reported here are extracted from a total of 16 different U95Av2 Ge-
neChips used under the various conditions described. The scanned images
were analyzed using Affymetrix Microarray Suite 4.2 software, using the
KCl-treated samples or the Lyt2a-transduced sample or the sample treated
with L cell supernatant as baseline. Further analysis was done using Mi-
croDB and desktop Mining Tool 3.0 software. Statistical significance of the
overnight LiCl treatment was tested using the freeware program signifi-
cance analysis of microarrays (SAM), version 1.12. The false discovery
rate was 9% for the SAM analysis. Hierarchical clustering was done on the
three time points analyzed using GeneLinker Gold 2.0 (Molecular Mining,
Cambridge, MA).
Transcription factor binding sites in promoter sequences were identified
using Alibaba 2.1 and Transfac 4.0 (gene regulation web site, http://www.
gene-regulation.com).
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TaqMan-based real-time quantitative PCR (RQ-PCR)
The mRNA expression of several target genes was tested using TaqMan-
based RQ-PCR. The isolated RNA was treated with 1 U of DNase I, and
subsequently, 1 g of RNA was transcribed to cDNA with avian myelo-
blastosis virus-reverse transcriptase (5 U), oligo(dT), and random hex-
anucleotide primers. A 1/20 cDNA mixture was used for RQ-PCR for each
primer/probe set and performed in duplicate. The cDNA was normalized to
GAPDH (Applied Biosystems, Foster City, CA). The RQ-PCR mixture of
25 l contained TaqMan Universal MasterMix, 900 nM primers, and 100
nM probe, and was run on the PRISM 7700 sequence detection system
containing a 96-well thermal cycler (Applied Biosystems). All primer and
probe sequences were designed with the Primer Express, version 1.5, soft-
ware (Applied Biosystems). The primer and probe sequences used were as
follows: CFOS (forward), 5-AACCTGTCAAGAGCATCAGCAG-3,
CFOS (reverse), 5-GAGCGGGCTGTCTCAGAGC-3, CFOS (probe), 5-
AGCTGAAGACCGAGCCCTTTGATGACTT-3; CL100 (forward), 5-
GCAGAGGCGAAGCATCATCT-3, CL100 (reverse), 5-CAGCACCT
GGGACTCAAACTG-3, and CL100 (probe), 5-CCAACTTCAGCTT
CATGGGCCAGC-3; GILZ (forward), 5-GCGTGAGAACACCCTGTT
GA-3, GILZ (reverse), 5-GGCTCAGACAGGACTGGAACTT-3, GILZ
(probe), 5-ACCCTGGCAAGCCCAGAGCAGCT-3; Brachyury (for-
ward), 5-TCCTTCCTGCTGGACTTTGTG-3, Brachyury (reverse), 5-
CATTCCCCGTTCGCGTACT-3, Brachyury (probe), 5-CGGCGGATA
ACCACCGCTGG-3; and Fibronectin (forward), 5-TGAGGAACATGG
TTTTAGGCG-3, Fibronectin (reverse), 5-CTTGGCCTATGCCTTATG
GG-3, Fibronectin (probe), 5-CACCGCCCACAACGGCCAC-3. For
murine genes, we used the following: CL100 (forward), 5-TGTTGGAT
TGTCGCTCCTTCT-3, CL100 (reverse), 5-TGAAGCGCACGTTCATC
GAG-3, and CL100 (probe), 5-TCAACGCCGGCCACATCGC-3; c-fos
(forward), 5-GGAGGTCTGCCTGAGGCTTC-3, c-fos (reverse), 5-
CACGTTGCTGATGCTCTTGAC-3, c-fos (probe), 5-CAACGACCCT
GAGCCCAAGCCAT-3; and c-jun (forward), 5-GACGGACCGTTC
TATGACTGC-3, c-jun (reverse), 5-GGAGGAACGAGGCGTTGA-3,
c-jun (probe) 5-TGGAAACGACCTTCTACGACGATGCC-3.
Reporter gene assays
293T cells were transfected with the luciferase reporter genes TATA-TOP
(TCF-optimal), TATA-FOP (mutated constructs), and natural promoter
constructs from Wnt target genes, together with a pCI-S33--catenin ex-
pression construct or a pCI-neo negative control construct. For natural
promoters, we constructed pGL3-fibonectin by cloning the fibronectin
1.7-kb promoter from FN-CAT (kindly provided by Dr. T. Gorogh (Uni-
versity of Kiel, Kiel, Germany)) into the pGL3 basic luciferase vector
(Promega, Madison, WI). The brachyury-promoter-luc was generated by
cloning the brachyury promoter from brachy-LacZ into pGL3-basic-lucif-
erase (brachyury promoter was kindly provided by Dr. B. Herrmann
(Max-Planck Institut fu¨r Immunbiologic, Freiburg, Germany)). The
Fos-luc reporter construct was kindly provided by Dr. T. Moeroey (Uni-
versity of Essen, Essen, Germany), and the 7 integrin promoter-luc by
Dr. G. Krissansen (University of Auckland, Auckland, New Zealand).
Luciferase assays were essentially done as described previously (19).
Results
The experimental system
It is well established that recombinant Wnt proteins are difficult to
produce in soluble form in vitro, with the notable exception of
murine Wnt3A, which can be made in biologically active form by
transfected L cells, a system that very recently has become avail-
able (http://www.stanford.edu/rnusse/assays/wntproteins.html).
Therefore, in almost all studies, researchers have relied on phar-
macological or genetic ways to induce Wnt signaling in vitro. In
this study, we have used the following three functional assays to
induce Wnt signaling (see Fig. 1): 1) treatment with LiCl, which
inhibits GSK-3, a key step in activating the Wnt pathway; 2)
retroviral expression of an activated form of -catenin; and 3)
supernatant from L cells transfected with Wnt3A expression vec-
tor. Treatment with LiCl has the advantage of its rapid action,
allowing time course investigations of Wnt signaling, but lacks
some specificity, because GSK-3 is also involved in regulation of
Rel/NF-AT transcription factors (23, 24). The retroviral system is
highly specific, but is not suited for time course experiments, be-
cause of the nature of the transduction process.
To isolate sufficiently high numbers of CD4CD8 immature
thymocytes that can be manipulated to induce Wnt signaling and
yield sufficient RNA for microarray experiments, we isolated hu-
man CD34 thymocytes. CD34 immature thymocytes were iso-
lated by magnetic beads to96% purity (Fig. 2A) and treated with
LiCl and KCl for various lengths of time. LiCl is a well-known
inducer of Wnt signaling, but its induction of TCF-dependent tran-
scription (the ultimate nuclear consequence of the Wnt cascade) is
not as strong in mature T lymphocytes as in other cell types (e.g.,
fibroblasts, epithelial cells (25)), but using sensitive reporter as-
says, a 5- to 10-fold induction of TCF-dependent transcription can
FIGURE 2. Lithium activates Wnt signaling in CD34 immature thy-
mocytes. A, Purification of immature CD34 thymocytes. Thymocytes
were purified by magnetic-bead isolation using the CD34 marker. In fresh
thymocytes, this CD34 population constitutes 1% of the cells, but in
frozen and subsequently thawed thymocytes, 3–7%, because of the selec-
tive loss of DP thymocytes after freeze/thawing. After MACS purification,
cells were 96% CD34. B, Lithium activates Wnt signaling in CD34
immature thymocytes. Purified CD34 thymocytes were treated for 6 h
with 20 mM LiCl or KCl. Cytospins were made and analyzed by immu-
nofluorescence using an Ab specific for dephosphorylated -catenin, fol-
lowed by an FITC-labeled secondary Ab. The clear increase in nuclear
-catenin indicates that Wnt signaling has been induced in these cells.
FIGURE 1. Simplified overview of Wnt signaling and stimuli used in
this study. The Wnt pathway can be activated at multiple levels, either by
stimulation of a Wnt ligand binding to a Frizzled receptor, by pharmaco-
logical inhibition of the GSK-3 kinase, or by providing the activated form
of -catenin. All three ways lead to the formation of an active -catenin-
Tcf transcription factor complex. The target genes of this pathway in the
thymus were unknown until this study.
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be observed in Jurkat T cells (data not shown). Therefore, we first
evaluated whether LiCl could induce Wnt signaling in primary
prothymocytes. These primary cells are not transfectable with re-
porter gene plasmids, and therefore, we used a recently developed
Ab that specifically recognizes the activated, dephosphorylated
form of -catenin (21, 22). LiCl indeed induced an increase in the
amount of dephosphorylated -catenin (Fig. 2B).
Wnt signaling induced by lithium treatment
We isolated RNA from CD34 thymocytes treated for 3, 6, or 18 h
with 20 mM LiCl, using KCl as control treatment. Microarray
analysis on Affymetrix U95 GeneChips (containing 12,600 genes)
revealed that 15 genes were up-regulated and 10 were down-
regulated 3-fold at the 3- and 6-h time points (Table I). During
the shorter time points (3 and 6 h), CHX was added to inhibit de
novo protein synthesis, thereby allowing identification of primary
target genes. For the 18-h time point, this was not possible, due to
cytotoxicity of longer CHX treatment. Most genes were slightly
more up-regulated after 6 h compared with 3-h treatment. The
up-regulated genes included proliferation-inducing transcription
factors such as c-fos, fosB, and other nuclear proteins (AHNAK,
glucocorticoid-induced lymphoid Zinc finger (GILZ), and cys-
teine-rich protein (CRP)1 and CRP2), cell cycle regulators (check-
point suppressor 1, cyclin-dependent kinase 15 kinase, cdc-like
kinase 2, and end-binding protein 3, which binds mitotic spindles),
and signaling molecules such as the CL100 dual-specificity phos-
phatase. Down-regulated genes also concerned nuclear targets
such as B cell translocation gene 1, breast cancer gene 2, nuclear
pore complex proteins (Nup88), c-myb, and signaling molecules
such as protein tyrosine phosphatase (PTPase) 2A. In addition, the
proapoptotic gene TRAIL was down-regulated. Several other
genes, including the known Wnt target gene in other cell types and
the T-box transcription factor Brachyury, also were induced, but at
a low level (2- to 2.5-fold).
To identify those genes that were statistically significantly
changed, we performed the 18-h treatment with biological tripli-
cates (six microarrays). SAM is a statistical test specifically de-
veloped for identification of such genes (26). A tuning parameter
 can be set corresponding to the number of false-positive genes
included in the set of genes identified as significantly changing in
expression. We chose to have less than one false-positive gene
included and performed SAM analysis on the three 18-h treatment
experiments. In doing so, we identified nine transcripts that sig-
nificantly changed, all up-regulated after LiCl treatment (see Table
II). Four of these genes were also found at the earlier time points,
suggesting that they are direct target genes. These are the CRP1
and CRP2 genes, which are highly conserved nuclear proteins with
a LIM/double-Zn finger motif, the large (700-kDa) nuclear protein
AHNAK (meaning “giant” in Hebrew), and the antiapoptotic, lym-
phoid-specific Zn finger protein GILZ. The other genes are appar-
ently induced with slower kinetics or may not be direct target
genes.
Another way to identify relevant genes in the wealth of microar-
ray data is clustering analysis. We performed hierarchical cluster-
ing on the three time points to identify clusters of genes that be-
haved similarly in terms of induction or repression (Fig. 3A). In
general, similar sets of genes were found as those described in
Tables I and II. As expected, the c-fos and fosB genes were most
highly induced after 3 and 6 h, but not after 18 h. To further
validate the differential expression of the identified genes, we per-
formed TaqMan-based RQ-PCR analysis for several transcripts. In
general, these data correlated well with the microarray findings
(Fig. 3B) for both the earlier and later time points.
Wnt signaling induced by retroviral transduction with
constitutively active -catenin
As a second treatment to induce Wnt signaling in CD34 imma-
ture thymocytes, we transduced the cells with either a mouse CD8
(Lyt2a) marker virus or a retrovirus encoding a constitutively ac-
tive form of -catenin linked via an IRES sequence to the Lyt2a
marker gene. The S33--catenin mutant is a specific activator of
Wnt signaling and provides a strong transactivation domain for its
nuclear partner Tcf-1, although not being under negative control of
Table I. Induced and repressed genes in CD34 thymocytes after
treatment with LiCla
Fold Change
(3 h)
Fold Change
(6 h)
Annotation induced genes
CDK15 kinase 4.3 1.3
CL100 phosphatase 3.2 2.0
EGR 1.7 3.0
HrpA0 4.4 3.0
hyp protein with Ankyrin repeats 1.6 3.2
HRV 2.7 3.4
-tubulin 2.6 3.4
ADP ribosylation factor-like
protein
4.6 3.6
GILZ 2.2 3.9
fosB 5.7 5.4
c-fos 6.8 4.5
EB3 protein 4.7 6.3
CRP 3.9 10.1
AHNAK 5.7 13.2
Checkpoint suppressor 4.0 13.8
Annotation repressed genes
diacylglycerol kinase 2.3 3
ISGF-3 1.9 3
CD8 -chain 4.6 3.1
ganglioside expression factor
2-like
1.7 3.2
PP2A 4.5 3.3
RNA polymerase II largest
subunit
2.6 3.4
phosphodiesterase 2.5 3.6
TRAIL 2.1 3.6
SLP-76 2.1 3.2
CD53 1.8 4.1
BTG nuclear protein 3.8 4.6
Nup88 1.8 4.8
a CD34 thymocytes were treated with LiCl or KCl for 3 or 6 h after which RNA
was isolated and probed on U95A GeneChips. Only genes that were expressed and
showed reliable up-regulation or down-regulation of 3-fold or more at at least one
time point are shown.
Table II. SAM analysis of triplicate microarraysa
Annotation
Average Fold Change
(LiCl/KCl)
CRP1 9.1
AHNAK 6.5
Fizzy-related cell cycle regulator 5.3
GILZ 6.2
Cysteine protease 4.7
Cellular fibronectin 5.5
S100 calcium binding protein 5.3
CRP2 6.5
Fibronectin, alternative splice 4.0
a Eighteen-hour treatment of CD34 thymocytes with LiCl and KCl. Three inde-
pendent experiments were performed (six U95A microarrays). Average fold change in
LiCl-treated CD34 thymocytes as compared to control (KCl treated).
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GSK-3, because one of the serine residues phosphorylated by
GSK-3 (S33) is mutated.
Immature CD34 thymocytes were transduced with the IRES-
Lyt2a marker gene or S33--catenin-IRES-Lyt2a with very similar
efficiencies (Fig. 4A), making them comparable for microarray
analysis. After transduction, RNA was isolated and used for mi-
croarray analysis. Similar to the experiments described above, only
a limited number of genes (n  14) was found to be differentially
regulated between the two treatments (Fig. 4B). Wnt target genes
identified after transduction with S33--catenin include c-fos,
fosB, the CL100 dual-specificity phosphatase, and 7 and p50,95
integrins, which were also found in the lithium experiments, as
well as JWA and nuclear restricted protein brain (NRPB). Down-
regulated were the structural proteins laminin and the proapoptotic
gene Human Requiem (HREQ) (both low, 2-fold). Repeat exper-
iments revealed similar clusters of genes, although the fold induc-
tion or repression varied. We reasoned that this could be caused by
differences in kinetics in the retroviral transduction experiments.
The complexities of transduction experiments, including integra-
tion, expression of -catenin, and induction of Wnt/TCF target
FIGURE 3. Target genes of the Wnt/-catenin/TCF pathway induced
by LiCl. A, Cluster analysis of Wnt target genes at 3, 6, and 18 h after
stimulation with LiCl. The data from the genes found to be differentially
induced or repressed with Microarray Suite software were used to perform
hierarchical clustering using GeneLinker Gold program. Although this
cluster analysis does not indicate statistical significance, similar sets of
genes were found as by SAM analysis. Red indicates induced genes, green
indicates repressed genes, and genes in black do not significantly change.
B, Independent validation of Wnt target genes by TaqMan RQ-PCR. RNA
was extracted from KCl- and LiCl-treated immature thymocytes. RQ-PCR
was done for c-fos, GILZ, CL100 phosphatase, and fibronectin. Data
shown are the average of triplicate measurements of one experiment of
three done. NT, Not tested (because fibronectin is not induced at earlier
time points).
FIGURE 4. Wnt target genes identified after transduction of CD34
immature thymocytes with a retrovirus encoding constitutively active
-catenin. A, Transduction of CD34 cells with a retrovirus encoding the
marker gene Lyt2a (murine CD8), or the S33--catenin-IRES-Lyt2a gene.
Cells were transduced in the presence of IL-7 for 2 days and stained with
Abs against CD34 and murine CD8. B, Genes induced or repressed by
induction of Wnt signaling as identified by Affymetrix microarray analysis
of Lyt2a- vs S33--catenin-IRES-Lyt2a-transduced immature thymocytes.
Shown is a dot plot for all genes expressed after 2 days of transduction.
Gene expression level is indicated in arbitrary fluorescence units. Genes
that do not change in expression (the vast majority) follow the line under
a 45° angle. The other lines indicate 2-, 3-, 5-, and 10-fold changes in gene
expression. C, TaqMan RQ-PCR validation of differential expression of
Wnt target genes after induction of Wnt signaling by transduction of S33-
-catenin. RNA extracted from Lyt2a- or S33--catenin-IRES-Lyt2a-
transduced cells was used for quantitative PCR analysis using GAPDH as
control gene. Results are shown as a ratio of S33--catenin vs Lyt2a sig-
nals. A time course was done at various time points (9–48 h) after initi-
ation of transduction. Shown are data for c-fos, fosB, CL100 phosphatase,
and GILZ.
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genes, do not allow direct assessment of the kinetics of induction
and consequently may cause variations in the target genes de-
tected. Therefore, we performed a time course experiment for
many time points after transduction of immature thymocytes with
S33--catenin using RQ-PCR as the readout for several Wnt target
genes (Fig. 4C). These kinetic experiments revealed a rapid induc-
tion of c-fos and GILZ (presumably by transcription of -catenin
from the unintegrated proviral DNA) followed by a lag time and a
2- to 2.5-fold induction at later time points (presumably expression
of -catenin from the integrated retroviral long terminal repeat).
Therefore, this induction of Wnt target genes in the time course
experiments confirms the microarray experiments.
Wnt signaling induced by stimulation with supernatant from
Wnt3A transfectants
During the course of our studies, L cells transfected with murine
Wnt3A were shown to produce biologically active Wnt3A. For
two reasons, this system may also be able to induce Wnt signaling
in human CD34 immature thymocytes. First, murine Wnt3A and
human Wnt3 are highly homologous (85% amino acid identity),
and second, Wnt3 (and Wnt3A) are expressed in human and mouse
thymus, although at much lower levels than Wnt1, Wnt4, and some
other Wnt family members (F. Weerkamp, M. R. M. Baert, B. A.
E. Naber, E. F. E. de Haas, E. E. L. Koster, J. J. M. van Dongen,
and F. J. T. Staal, manuscript in preparation).
Immature thymocytes were incubated with supernatant from
Wnt3A-transfected L cells and from parental L cells (negative con-
trol) and analyzed on Western blot using the above-described Ab
against the active (dephosphorylated) form of -catenin. Wnt3A-
containing supernatant was able to induce active -catenin in im-
mature thymocytes, indicating that Wnt signaling was active in
these cells (Fig. 5). We next used similar conditions for microarray
experiments. Genes that were induced or repressed 2.5-fold are
listed in Table III. The genes for Fos and Jun and several other
transcription factors were induced, such as Lim domain only
(LMO)2, NRPB, and cAMP responsive element modulator, and at
lower levels of significance, CL100 phosphatase, 7 integrin, and
AHNAK. Cytochrome P450, which was modestly induced after
-catenin transduction, was more clearly induced after Wnt3A
stimulation. Interestingly, the most highly induced gene after
Wnt3A stimulation encodes an ubiquitin ligase, known to be in-
volved in degradation of -catenin, thereby providing a negative
feedback on Wnt signaling. Among the down-regulated genes,
several proteases that modify extracellular matrix (ECM) compo-
nents stand out (matrix metalloproteinase 7 (MMP7), tryptase1),
potentially influencing cell adhesion to ECM components.
We again validated the microarray results using RQ-PCR for the
Wnt target genes c-fos, CL100 phosphatase, and 7 integrin. For
unknown reasons, the differential expression as detected by RQ-
PCR was significantly higher than detected by microarray, namely,
c-fos, 5-fold; CL100 phosphatase, 4.8-fold; and 7 integrin, 2.2-
fold (data not shown), more in line with the fold induction in the
retroviral transduction experiments.
TCF-reporter gene assays
To validate the identification of target genes of the Wnt/-catenin/
TCF pathway, we performed two different types of experiments on
selected target genes. First, we tested the promoters of several
genes identified by different treatments ( fibronectin, c-fos,
brachyury, and 7 integrin) for induction of TCF-dependent tran-
scription in transient transfection assays with luciferase reporters.
Second, we checked expression of core target genes in thymocyte
subsets of Tcf-1(VII)/ mice.
Reporter gene experiments reveal much smaller differences with
natural promoters (containing binding sites for many transcription
factors in addition to the one being tested) than with artificial pro-
moters consisting of multimerized binding sites for the tested tran-
scription factors. Nevertheless, we could demonstrate a small in-
duction of promoter activity for fibronectin, brachyury, and 7
integrin (Fig. 6), whereas for fos, the effect was minimal, probably
because our 600-bp fos promoter construct contained only subop-
timal TCF binding sites. Most likely other promoter/enhancer sites
around the c-fos gene contain additional TCF sites. Functional
identification of such sites is a daunting task, given that enhancers
can lie 50 kb up- and downstream of their target genes. Our
reporter assays are consistent with the microarray and RQ-PCR
data in identification of Wnt target genes, but show a smaller in-
duction. For instance, although the induction of fibronectin by LiCl
FIGURE 5. Murine Wnt3A activates Wnt signaling in immature
CD34 thymocytes. CD34 DN thymocytes were isolated and incubated
with supernatant from parental L cells or L cells stably transfected with a
Wnt3A expression construct. As a positive control, purified CD34 thy-
mocytes were also treated for 6 h with 20 mM LiCl or KCl. Cells were
lysed in boiling SDS sample buffer and analyzed by Western blotting with
anti-ABC, an Ab specific for the activated form of -catenin (bottom) and
with an Ab recognizing the total -catenin pool (top). The expected in-
crease in total -catenin levels after LiCl treatment was also seen after
stimulation with Wnt3A.
Table III. Stimulation of CD34 immature thymocytes with Wnt3Aa
Fold Change (Wnt3A
vs L Cell)
Annotation induced genes
Ubiquitin ligase E2 9
GPNMB glycoprotein 8
c-jun 5.7
CYBB 4.6
LMO2 4.3
HRY 3.7
ENC1 nuclear matrix protein 2.8
EST (?) 2.6
MIR-7 2.6
Dual-specificity PTPase 6 2.6
CREM 2.6
c-fos 2.5
TSH-R 2.5
cytP450 2.5
IFI30 2.5
TIEG 2.5
Annotation repressed genes
NK4 5.8
MMP7 matrilysin 4.8
PDCL 4.3
IL1 3.8
tryptase1 3.1
TNFRSF4 2.9
GRO1 2.9
MAP4K2 2.5
a Induced and repressed genes (2.5-fold) after stimulation with parental L cell
supernatant vs Wnt3A-containing supernatant for 4 h. A 2.5-fold threshold is set,
because this is the lowest difference that can be reliably validated by RQ-PCR.
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was 4-fold as assessed by microarray, the induction of fibronec-
tin promoter activity in the luciferase reporter gene assay was
barely 2-fold. A likely explanation for this difference is that the
fibronectin reporter construct lacks important TCF sites that are
activated by Wnt signals in vivo. Similarly low induction of the
fibronectin promoter by Wnt signals has recently been reported for
Xenopus fibronectin (27). Our reporter gene data also show that
genes identified by only one stimulus, such as brachyury and fi-
bronectin, behave as target genes in isolated reporter gene assays,
whereas in functional assays they may not be bona fide Wnt targets
in prothymocytes because of the lack of induction by Wnt3A or
S33--catenin. Thus, we regard c-fos as a true Wnt target gene,
because it was found in all three conditions to induce Wnt signal-
ing (including those under cyclohexamide treatment), even though
in the reporter gene assays with the short c-fos promoter, we could
not demonstrate induction by Wnt signals. In contrast, genes such
as fibronectin or brachyury were only found after lithium treatment
and are Wnt targets in other cell types, but probably not in
thymocytes.
We checked the expression of the core set of seven Wnt target
genes by RQ-PCR throughout T cell development (see Table IV).
Interestingly, many of these genes were expressed at the highest
level in CD34 thymocytes (c-fos, CL100 PTPase, heat shock
protein 70 (hsp70)), suggesting that their expression is signifi-
cantly regulated by Wnt signals. Undoubtedly, other pathways also
regulate expression of Wnt target genes, in particular those found
to be highly expressed at later stages of development (c-jun, fosB).
Expression of Wnt target genes in Tcf-1-null mice
(Tcf-1(VII)/)
It is likely that important Wnt target genes are evolutionarily con-
served in the same types of cells. Therefore, we checked the ex-
pression of three prominent target genes, c-fos, c-jun, and CL100
phosphatase in mice that lack the Tcf-1 transcription factor (here-
after referred to as Tcf-1(VII)/). These mice are not able to
induce Wnt target genes because of the lack of nuclear integration
of Wnt signals. Young Tcf-1(VII)/ (12 wk) mice have an
incomplete block in T cell development at the ISP stage, later (6
mo of age) followed by a more complete block at the DN stage.
We used thymi from 7-wk-old wild-type control mice and Tcf-
1(VII)/ mice, sorted the DN and ISP cell populations, and
checked the levels of Wnt target genes by RQ-PCR (Fig. 7A).
Although the levels of c-fos, c-jun, and CL100 phosphatase were
not dramatically different in the DN stage (where cells still develop
normally in Tcf-1(VII)/ mice of this age), the levels of c-fos and
c-jun were dramatically reduced in ISP cells (Fig. 7B). In addition,
the levels of CL100 phosphatase were 3-fold reduced. These ex-
periments underscore that these genes function as Wnt target genes
and confirm the microarray experiments.
Discussion
Target genes of the Wnt/-catenin/TCF pathway in thymocytes
have remained elusive. In this study, we have investigated the
target genes induced by Wnt signals that activate the -catenin/
TCF complex in CD34 DN thymocytes (prothymocytes) using
three different functional assays to activate Wnt signaling in vitro.
Remarkably, no markers of T cell differentiation were induced; we
instead found that markers of proliferation and cell-cell adhesion
were up-regulated. This is consistent with the notion that Wnt pro-
teins can provide proliferative signals for stem cells in various
tissues, such as crypt cells in the colon, HSC, pro-B cells, and
pro-T cells.
In general, a relatively small number of Wnt target genes (in
total, 30) was found. LiCl, although widely used as a pharma-
cological agent to mimic Wnt signaling, is somewhat nonspecific,
as is reflected by the much larger number of genes found after LiCl
treatment than with the other two stimuli (Fig. 8). By definition,
genes identified by transduction with S33--catenin or Wnt3A
stimulation are Wnt target genes. A core set of genes is induced by
both specific stimuli: c-fos, fosB, CL100 phosphatase, integrin
p150,95, c-jun, hsp70, and NRPB; most of these are induced by
LiCl as well. Because the three functional stimuli differ in modes
of action, signal strengths, and kinetics of induction, it is not sur-
prising that also different genes were found, although the func-
tional clusters were highly comparable. The identified target genes
can be clustered into several groups: genes encoding transcription
FIGURE 6. TCF- reporter gene analysis of several Wnt target genes.
Promoters of c-fos, fibronectin, and brachyury were cloned in front of a
luciferase reporter gene and used in transient transfection assays together
with cotransfection of S33--catenin or vector control. For reference, the
optimal Tcf reporter construct (TOP), consisting of multimerized binding
sites for TCF, was included as well (50-fold activation; not shown). The
brachyury and 7 integrin promoter constructs contain one optimal Tcf
binding site, the fibronectin promoter contains two, whereas the c-fos pro-
moter used contains only two suboptimal sites. Data shown are the average
of duplicate measurements of one experiment of three done. The luciferase
values obtained with vector control were set as 1.0.
Table IV. Expression of core Wnt target genes during thymocyte development as measured by RQ-PCRa
Stage c-fos fosB c-jun CL100 PTPase NRPB p150,95 hsp70
CD34CD1a 92 1 1 466 1 1 522
CD34CD1a 93 0.4 10 367 1 1 561
DN (CD34) 19 6 22 49 1 1 11
DP 30 9 32 64 1 1 15
CD4 SP 55 11 16 37 1 1 4
CD8 SP 80 35 26 110 1 1 5
a Data are presented as 1000 times the level of a particular transcript compared with the level of GAPDH as housekeeping
gene (i.e., 1000 corresponds to the level of GAPDH in a particular subset). Subpopulations were sorted from the human thymus
to 95% purity.
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factors and other nuclear proteins (c-fos, fosB, AHNAK, GILZ,
NRPB, LMO), together forming a cluster of genes involved in cell
proliferation; signaling molecules in particular phosphatases
(CL100 phosphatase); molecules involved in apoptosis (GILZ,
TRAIL); cell adhesion molecules ( fibronectin, laminin, p150,95,
7 integrin); and ECM modifiers (MMP7, tryptase1).
Some genes found only after lithium treatment may be true Wnt
targets in thymocytes as well, because they have been identified as
Wnt targets in other species, including the T-box transcription fac-
tors brachyury in murine ES cells (28) and cellular fibronectin in
Xenopus (27). Promoters of these genes are responsive to -cate-
nin (see Fig. 5). However, because they were not significantly
induced by S33-catenin transduction nor Wnt3A stimulation, we
have excluded them in the cluster of 31 target genes.
It should be noted that a number of known Wnt target genes in
other tissues are apparently not induced by Wnt signaling in
CD34 thymocytes. Of note, CyclinD1 and c-myc expression were
not changed, even though both genes are represented on the arrays
used. In addition, expression of antiapoptotic gene Bcl-x did not
change, even though this gene has been proposed to play role in
TCF-induced protection against apoptosis in DP thymocytes (20).
Apparently, Wnt signaling differs between immature and more ma-
ture stages of T cell differentiation. However, we cannot exclude
the possibility that Wnt signaling in vivo can provide differentia-
tion signals to prothymocytes, or that the in vitro functional assays
used in this study induce differentiation in a small subset of cells
that cannot be detected by microarray analysis.
The lack of known T cell differentiation genes among the iden-
tified target genes seems at variance with data from Gounari et al.
(29), who showed that transgenic mice overexpressing constitu-
tively active -catenin seem to bypass signals transmitted via the
pre-TCR and differentiate into DP cells. However, in vivo differ-
entiation experiments cannot evaluate the effects of constitutively
active -catenin per differentiation stage. For example, the pre-
TCR provides proliferative signals as well. These proliferative sig-
nals superimposed on other differentiation signals given in the con-
text of the thymus might be sufficient to induce differentiation.
However, the DP and SP cells generated by somatic activation of
-catenin lack rearranged TCR chains and do not survive prop-
erly (29), indicating that the proliferative signals provided by ec-
topic activation of Wnt signaling do not mimic normal prolifera-
tion and differentiation signals emanating from the pre-TCR. In
conclusion, our results support the idea that Wnt signals induce
proliferation, but not differentiation of the earliest progenitor cell
compartment in the thymus. This is consistent with a recent report
by Sen and colleagues (30) showing a proliferative defect in thy-
mocytes of Wnt4/Wnt1-null mice.
c-fos is one of the target genes induced the strongest (5-fold)
and found in all three types of experiments, whereas c-jun is found
in the Wnt3A and S33 -catenin experiments. Both c-fos and c-jun
FIGURE 7. Expression of Wnt target genes is decreased in Tcf-1(VII)/ mice compared with wild-type mice. Thymi from wild-type and Tcf-1(VII)/
mice were sorted in DN and ISP populations based on staining with CD4, CD8, and CD3. DN cells were defined as CD4CD8CD3, and ISP cells were
defined as CD8CD3. Starting populations and reanalysis of sorted populations are shown in CD4, CD8 FACS plots under A. All sorted populations were
98% pure and CD3 (not shown). RNA was extracted and the expression of c-fos, c-jun, and CL100 phosphatase was analyzed in DN and ISP cells by
RQ-PCR, with GAPDH as control (B). Values are given as percentage of GAPDH  1000.
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are well-known transcription factors that mediate cell cycle pro-
gression and proliferation (31, 32). c-fos-null mice show a reduced
cellularity in the thymus (33), without any strong blocks at a par-
ticular stage, consistent with a proliferative defect at various stages
of development and somewhat reminiscent of thymi from young
Tcf-1(VII)/ mice. FOS family members (fos, fosB, fra1) form
the so-called AP1 complexes by heterodimerization with JUN
family members (jun, junB, junD). Because redundancy between
these factors (e.g., between fos and fosB) can affect the conse-
quence of gene-targeting experiments, dominant-negative mole-
cules may better reveal the importance of fos/jun in biological
processes. Mice with a dominant-negative c-jun have been made
(34) and display a defect in cell cycle progression during the tran-
sition of DN to DP thymic development, indicating that fos/jun
transcription factors promote proliferation at DN and ISP stages.
These are the same stages of development affected in Tcf-
1(VII)/ mice. Given that fos/jun transcription factors are
strongly decreased in expression in those thymic subpopulations
that are affected in Tcf-1(VII)/ mice (Fig. 7), lack of Wnt-in-
duced fos/jun-mediated proliferation explains the defect in Tcf-
1(VII)/ mice. Thus, our findings provide a molecular mecha-
nism for the developmental defect in Tcf-1(VII)/ mice.
Interestingly, in a differential screen between genes expressed in
CD34CD38 HSC vs CD34CD38 progenitor cells in the hu-
man bone marrow, Eaves and colleagues (35) have identified Fos
and Jun as genes highly expressed in HSC (CD34CD38) com-
pared with more mature progenitor cells (CD34CD38), consis-
tent with a role of these factors in proliferation of stem cells.
Among the several signaling molecules found, CL100 dual-
specificity phosphatase was highly induced in all three types of
experiments. This gene encodes a mitogen-activated protein kinase
3 phosphatase implicated in cell proliferation (36, 37). Interest-
ingly, this gene is preferentially expressed in CD34CD38 HSC
compared with CD34CD38 cells (38), similar to c-fos (see
above), suggesting that Wnt signaling in early progenitor cells in
the thymus induces similar target genes as those expressed in HSC.
Several genes involved in cell-cell adhesion, including fibronec-
tin and integrins 7 and p150,95, were found as target genes as
well. These proteins are involved in compartmentalization and cell
migration within the cortical region of the thymus and perhaps in
attracting common lymphoid progenitors to the thymus. Petrie and
coworkers (39) have found that DN1 cells are confined to the peri-
medullary cortex, whereas DN2 and DN3 cells are found in the
outer cortical regions. At the transition of DN1 to DN3 cell
(CD34 pro-T cell to pre-TCR T cell), thymocytes up-regulate
7 integrin expression (7 heterodimerized with 4 or E inte-
grins) and become more adhesive to fibronectin. Thus, Wnt signals
may assure a proper migration of precursors along this stromal
matrix or keep cells localized to a certain region of the cortex
where cells receive proliferative signals before pre-TCR expres-
sion and TCR selection.
Based on these findings, we propose that Wnt-induced -cate-
nin/TCF target genes in immature thymocytes are not directly in-
volved in inducing differentiation, but instead provide proliferative
signals (for instance, via c-fos and c-jun) to induce cell division in
the precursor cell compartment of the thymus (Fig. 9). In fact,
because only very few progenitor cells from bone marrow or fetal
liver seed the thymus, a vigorous proliferation of the most imma-
ture cells in the thymus is required. This has been recognized for
over two decades by various groups and is still studied (40–42).
The nature of this proliferative signal is provided by cytokines
such as IL-7 and stem cell factor, but apparently also by Wnt
proteins (19). Additionally, Wnt signals can be involved in the
migration of immature thymocytes through thymic cortex or in
confinement of precursor cells to those cortical regions where pro-
liferation can occur (Fig. 9). This may help preventing TCR gene
rearrangement at proliferative stages of development or occurrence
of selection processes at the corticomedullary junction at inappro-
priate stages of development. Apparently, the Wnt/-catenin/TCF
pathway provides both proliferative signals for immature thymo-
cytes to maintain the thymic precursor cell compartment and ad-
hesion signals that assure that T cell development proceeds at the
appropriate anatomical sites in the thymus.
FIGURE 8. Venn diagram of Wnt target genes in prothymocytes iden-
tified by three different functional stimulations. The area of each circle is
proportional to the number of target genes identified by each stimulus. Note
that not all genes induced by LiCl are bona fide Wnt targets. A core set of
7 genes is identified among the 31 Wnt target genes defined.
FIGURE 9. Model: Wnt signals induce proliferation and cell adhesion
of immature CD34 thymocytes. HSC or common lymphoid progenitors
are seeding the thymus from the bone marrow and undergo proliferation,
partially driven by Wnt signals, but also by cytokines such as IL-7 and stem
cell factor (1). Cells migrate to the outer cortex via different integrins and
ECM components, some of which are Wnt targets (7 integrin, fibronec-
tin). After this proliferative stage, rearrangement of TCR occurs, leading
to expression of the pre-TCR (/pT) on the cell membrane. This gener-
ates another stage of proliferation (2) where Wnt signaling may play a role
after which cells start expressing CD4 and CD8 to become DP thymocytes
(3), followed by rearrangement of TCR and positive and negative selec-
tion at the corticomedullary junction (3). Mature SP thymocytes subse-
quently end up in the medulla (4).
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